Frankfurt - Delayed Quote EUR

RTW Biotech Opportunities Ltd (0BM.F)

1.1700 +0.0100 (+0.86%)
As of 8:09 AM GMT+2. Market Open.
Loading Chart for 0BM.F
DELL
  • Previous Close 1.1600
  • Open 1.1700
  • Bid 1.1700 x --
  • Ask 1.2800 x --
  • Day's Range 1.1700 - 1.1700
  • 52 Week Range 0.9650 - 1.2500
  • Volume 20,000
  • Avg. Volume 322
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2880
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

www.rtwfunds.com/rtw-biotech-opportunities-ltd

--

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Related News

Performance Overview: 0BM.F

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0BM.F
3.31%
MSCI WORLD
4.70%

1-Year Return

0BM.F
10.38%
MSCI WORLD
17.54%

3-Year Return

0BM.F
--
MSCI WORLD
9.58%

5-Year Return

0BM.F
--
MSCI WORLD
9.58%

Compare To: 0BM.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0BM.F

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1,994.76%

  • Return on Assets (ttm)

    -0.47%

  • Return on Equity (ttm)

    21.42%

  • Revenue (ttm)

    4.17M

  • Net Income Avi to Common (ttm)

    83.19M

  • Diluted EPS (ttm)

    -0.2880

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.72M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -63.61M

Company Insights: 0BM.F